News | Nuclear Imaging | May 10, 2016

MEDraysintell to Showcase Nuclear Imaging Reports at SNMMI 2016

Series of reports include nuclear medicine, cyclotrons, brachytherapy and proton therapy

Medraysintell, SNMMI 2016, nuclear imaging reports

May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) congress, June 11-15, in San Diego. The reports contain over 1,800 pages of intelligence covering nuclear medicine, cyclotrons, brachytherapy and proton therapy.

Nuclear Medicine World Market Report & Directory, Edition 2015 is a 930-page report and directory describing and analyzing over 335 radiopharmaceuticals and radionuclides, and more than 160 companies and institutions active in nuclear medicine.

Cyclotrons used in Nuclear Medicine, Edition 2015 is a 350-page report providing an extensive review of all cyclotrons around the world (over 1,200) with an exhaustive profile of the 14 companies active in this market.

The global brachytherapy industry is evaluated in a new and updated MEDraysintell report and directory, providing in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.

Proton Therapy world market report, Edition 2015 is the most comprehensive evaluation of the world proton therapy industry. This report includes a complete market review and contains a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.

MEDraysintell reports and directories can be customized to specific areas or modalities. Sample pages and complete table of contents are available upon request.

For more information: www.medraysintell.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...